tirzepatide makes me poop Let’s talk about 💩… , ., If you’re on a GLP1 there’s no way of getting around the conversation, 💩 is eventually going to come up (or out 🤣). , ., Here are some tried and true ways I’ve found to manage 18 Possible Side Effects of

Change from baseline in A1C was the primary efficacy end point in all LEAD trials

Both Retatrutide and Survodutide demonstrate improvements across multiple metabolic parameters

Every subsequent dose drawn from that vial will deliver less active compound than intended

Liraglutide is a glucagon-like peptide-1 receptor agonist

Your provider sets realistic expectations and adjusts your plan as you go

Results from this trial showed that Miplyffa, in combination with miglustat, halted disease progression through 12 months of treatment, as evidenced by a decrease of 0.2 points from baseline on the rescored 4-domain NPC Clinical Severity Scale